These costs were compared across VA levels in the better-seeing eye, and the observed differences did not reach statistical significance [ 12 ], thus we used the same figure in the model for each VA state.
← all excerpts
Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema.
1
—
—